CN Patent

CN119604494A — Pcsk9抑制剂及其使用方法

Assigned to AstraZeneca AB · Expires 2025-03-11 · 1y expired

What this patent protects

本文公开了PCSK9抑制剂。本文还公开了使用PCSK9抑制剂治疗某些疾病和病症的方法。

USPTO Abstract

本文公开了PCSK9抑制剂。本文还公开了使用PCSK9抑制剂治疗某些疾病和病症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN119604494A
Jurisdiction
CN
Classification
—
Expires
2025-03-11
Drug substance claim
No
Drug product claim
No
Assignee
AstraZeneca AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.